Aclaris Therapeutics Inc.

10/14/2025 | Press release | Distributed by Public on 10/14/2025 05:00

Regulation FD Presentation (Form 8-K)

Aclaris Therapeutics Inc. published this content on October 14, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on October 14, 2025 at 11:00 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]